Allergy promotes alopecia areata in a subset of patients

Exp Dermatol. 2020 Mar;29(3):239-242. doi: 10.1111/exd.14027. Epub 2019 Sep 3.

Abstract

In this commentary, we focus on allergy as a facilitating factor in the pathogenesis of alopecia areata (AA). From previous studies on AA, it is well known that subsets of patients can have one or more of; seasonal relapse, comorbid atopic rhinitis, asthma and dermatitis, lesion infiltrating eosinophils and plasma cells, high levels of total IgE, specific IgE for house dust mites (HDMs), and/or disrupted skin barrier function by the evaluation of filaggrin. Allergy and AA share a similar genetic background; both contributing to an immune reaction imbalance. Furthermore, adjunctive treatment with antihistamines, or desensitization for HDM, can reduce the severity of alopecia in atopic AA patients. Therefore, allergies may contribute to the onset and relapse of AA. Identification of an allergic or atopic immune component in AA patient subsets may indicate adjunctive treatment intervention measures against allergies should be taken which may improve the success of conventional AA treatment.

Keywords: allergy; alopecia areata; atopy; dust mites.

MeSH terms

  • Allergens / immunology
  • Alopecia Areata / complications*
  • Alopecia Areata / immunology
  • Animals
  • Filaggrin Proteins
  • Hair Follicle / immunology
  • Histamine Antagonists
  • Humans
  • Hypersensitivity / complications*
  • Hypersensitivity / immunology
  • Immune System
  • Immunoglobulin E / immunology
  • Intermediate Filament Proteins
  • Pyroglyphidae
  • Skin / immunology
  • Steroids / therapeutic use
  • Th1 Cells
  • Th2 Cells

Substances

  • Allergens
  • FLG protein, human
  • Filaggrin Proteins
  • Histamine Antagonists
  • Intermediate Filament Proteins
  • Steroids
  • Immunoglobulin E